IBDEI069 ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15164,0)
 ;;=N39.41^^56^641^117
 ;;^UTILITY(U,$J,358.3,15164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15164,1,3,0)
 ;;=3^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,15164,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,15164,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,15165,0)
 ;;=R35.0^^56^641^69
 ;;^UTILITY(U,$J,358.3,15165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15165,1,3,0)
 ;;=3^Micturition Frequency
 ;;^UTILITY(U,$J,358.3,15165,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,15165,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,15166,0)
 ;;=R35.1^^56^641^82
 ;;^UTILITY(U,$J,358.3,15166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15166,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,15166,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,15166,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,15167,0)
 ;;=R39.11^^56^641^70
 ;;^UTILITY(U,$J,358.3,15167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15167,1,3,0)
 ;;=3^Micturition Hesitancy
 ;;^UTILITY(U,$J,358.3,15167,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,15167,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,15168,0)
 ;;=R39.16^^56^641^107
 ;;^UTILITY(U,$J,358.3,15168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15168,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,15168,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,15168,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,15169,0)
 ;;=R36.0^^56^641^111
 ;;^UTILITY(U,$J,358.3,15169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15169,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,15169,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,15169,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,15170,0)
 ;;=R36.9^^56^641^112
 ;;^UTILITY(U,$J,358.3,15170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15170,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,15170,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,15170,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,15171,0)
 ;;=R80.1^^56^641^96
 ;;^UTILITY(U,$J,358.3,15171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15171,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,15171,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,15171,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,15172,0)
 ;;=R80.0^^56^641^94
 ;;^UTILITY(U,$J,358.3,15172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15172,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,15172,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,15172,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,15173,0)
 ;;=R80.8^^56^641^97
 ;;^UTILITY(U,$J,358.3,15173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15173,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,15173,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,15173,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,15174,0)
 ;;=R80.3^^56^641^93
 ;;^UTILITY(U,$J,358.3,15174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15174,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,15174,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,15174,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,15175,0)
 ;;=R80.9^^56^641^98
 ;;^UTILITY(U,$J,358.3,15175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15175,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,15175,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,15175,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,15176,0)
 ;;=Z87.442^^56^641^86
 ;;^UTILITY(U,$J,358.3,15176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15176,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,15176,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,15176,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,15177,0)
 ;;=N18.1^^56^641^15
 ;;^UTILITY(U,$J,358.3,15177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15177,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,15177,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,15177,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,15178,0)
 ;;=N18.2^^56^641^16
 ;;^UTILITY(U,$J,358.3,15178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15178,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,15178,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,15178,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,15179,0)
 ;;=N18.4^^56^641^20
 ;;^UTILITY(U,$J,358.3,15179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15179,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,15179,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,15179,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,15180,0)
 ;;=N18.5^^56^641^21
 ;;^UTILITY(U,$J,358.3,15180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15180,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,15180,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,15180,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,15181,0)
 ;;=Q61.3^^56^641^89
 ;;^UTILITY(U,$J,358.3,15181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15181,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,15181,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,15181,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,15182,0)
 ;;=N20.1^^56^641^11
 ;;^UTILITY(U,$J,358.3,15182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15182,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,15182,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,15182,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,15183,0)
 ;;=N18.9^^56^641^22
 ;;^UTILITY(U,$J,358.3,15183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15183,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,15183,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,15183,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,15184,0)
 ;;=N18.6^^56^641^32
 ;;^UTILITY(U,$J,358.3,15184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15184,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,15184,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,15184,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,15185,0)
 ;;=N52.9^^56^641^49
 ;;^UTILITY(U,$J,358.3,15185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15185,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,15185,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,15185,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,15186,0)
 ;;=N32.81^^56^641^84
 ;;^UTILITY(U,$J,358.3,15186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15186,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,15186,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,15186,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,15187,0)
 ;;=Q61.2^^56^641^88
 ;;^UTILITY(U,$J,358.3,15187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15187,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,15187,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,15187,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,15188,0)
 ;;=N41.1^^56^641^92
 ;;^UTILITY(U,$J,358.3,15188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15188,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,15188,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,15188,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,15189,0)
 ;;=N11.9^^56^641^100
 ;;^UTILITY(U,$J,358.3,15189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15189,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,15189,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,15189,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,15190,0)
 ;;=N20.9^^56^641^118
 ;;^UTILITY(U,$J,358.3,15190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15190,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,15190,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,15190,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,15191,0)
 ;;=R97.20^^56^641^31
 ;;^UTILITY(U,$J,358.3,15191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15191,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,15191,1,4,0)
 ;;=4^R97.20
 ;;^UTILITY(U,$J,358.3,15191,2)
 ;;=^334262
 ;;^UTILITY(U,$J,358.3,15192,0)
 ;;=N52.36^^56^641^36
 ;;^UTILITY(U,$J,358.3,15192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15192,1,3,0)
 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
 ;;^UTILITY(U,$J,358.3,15192,1,4,0)
 ;;=4^N52.36
 ;;^UTILITY(U,$J,358.3,15192,2)
 ;;=^5138933
 ;;^UTILITY(U,$J,358.3,15193,0)
 ;;=N52.37^^56^641^37
 ;;^UTILITY(U,$J,358.3,15193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15193,1,3,0)
 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
 ;;^UTILITY(U,$J,358.3,15193,1,4,0)
 ;;=4^N52.37
 ;;^UTILITY(U,$J,358.3,15193,2)
 ;;=^5138934
 ;;^UTILITY(U,$J,358.3,15194,0)
 ;;=N52.35^^56^641^38
 ;;^UTILITY(U,$J,358.3,15194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15194,1,3,0)
 ;;=3^Erectile Dysfunction After Radiation Therapy
 ;;^UTILITY(U,$J,358.3,15194,1,4,0)
 ;;=4^N52.35
 ;;^UTILITY(U,$J,358.3,15194,2)
 ;;=^5138932
 ;;^UTILITY(U,$J,358.3,15195,0)
 ;;=R31.21^^56^641^58
 ;;^UTILITY(U,$J,358.3,15195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15195,1,3,0)
 ;;=3^Hematuria,Microscopic,Asymptomatic
 ;;^UTILITY(U,$J,358.3,15195,1,4,0)
 ;;=4^R31.21
 ;;^UTILITY(U,$J,358.3,15195,2)
 ;;=^5139198
 ;;^UTILITY(U,$J,358.3,15196,0)
 ;;=R31.29^^56^641^59
 ;;^UTILITY(U,$J,358.3,15196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15196,1,3,0)
 ;;=3^Hematuria,Microscopic,Other
 ;;^UTILITY(U,$J,358.3,15196,1,4,0)
 ;;=4^R31.29
 ;;^UTILITY(U,$J,358.3,15196,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,15197,0)
 ;;=R39.198^^56^641^72
 ;;^UTILITY(U,$J,358.3,15197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15197,1,3,0)
 ;;=3^Micturition,Oth Difficulties
 ;;^UTILITY(U,$J,358.3,15197,1,4,0)
 ;;=4^R39.198
 ;;^UTILITY(U,$J,358.3,15197,2)
 ;;=^5019347
 ;;^UTILITY(U,$J,358.3,15198,0)
 ;;=R39.191^^56^641^74
 ;;^UTILITY(U,$J,358.3,15198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15198,1,3,0)
 ;;=3^Need to Immediately Re-Void
 ;;^UTILITY(U,$J,358.3,15198,1,4,0)
 ;;=4^R39.191
 ;;^UTILITY(U,$J,358.3,15198,2)
 ;;=^5139199
 ;;^UTILITY(U,$J,358.3,15199,0)
 ;;=R39.192^^56^641^73
 ;;^UTILITY(U,$J,358.3,15199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15199,1,3,0)
 ;;=3^Micturition,Position Dependent
 ;;^UTILITY(U,$J,358.3,15199,1,4,0)
 ;;=4^R39.192
 ;;^UTILITY(U,$J,358.3,15199,2)
 ;;=^5139200
 ;;^UTILITY(U,$J,358.3,15200,0)
 ;;=R97.21^^56^641^103
 ;;^UTILITY(U,$J,358.3,15200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15200,1,3,0)
 ;;=3^Rising PSA After Tx for Prostate CA
 ;;^UTILITY(U,$J,358.3,15200,1,4,0)
 ;;=4^R97.21
 ;;^UTILITY(U,$J,358.3,15200,2)
 ;;=^5139228
 ;;^UTILITY(U,$J,358.3,15201,0)
 ;;=N50.82^^56^641^104
 ;;^UTILITY(U,$J,358.3,15201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15201,1,3,0)
 ;;=3^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,15201,1,4,0)
 ;;=4^N50.82
 ;;^UTILITY(U,$J,358.3,15201,2)
 ;;=^5138930
 ;;^UTILITY(U,$J,358.3,15202,0)
 ;;=N50.812^^56^641^108
 ;;^UTILITY(U,$J,358.3,15202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15202,1,3,0)
 ;;=3^Testicular Pain,Left Side
 ;;^UTILITY(U,$J,358.3,15202,1,4,0)
 ;;=4^N50.812
 ;;^UTILITY(U,$J,358.3,15202,2)
 ;;=^5138928
 ;;^UTILITY(U,$J,358.3,15203,0)
 ;;=N50.811^^56^641^109
 ;;^UTILITY(U,$J,358.3,15203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15203,1,3,0)
 ;;=3^Testicular Pain,Right Side
 ;;^UTILITY(U,$J,358.3,15203,1,4,0)
 ;;=4^N50.811
 ;;^UTILITY(U,$J,358.3,15203,2)
 ;;=^5138927
 ;;^UTILITY(U,$J,358.3,15204,0)
 ;;=N35.919^^56^641^114
 ;;^UTILITY(U,$J,358.3,15204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15204,1,3,0)
 ;;=3^Urethral Stricture,NOS,Male
 ;;^UTILITY(U,$J,358.3,15204,1,4,0)
 ;;=4^N35.919
 ;;^UTILITY(U,$J,358.3,15204,2)
 ;;=^5157412
 ;;^UTILITY(U,$J,358.3,15205,0)
 ;;=N35.92^^56^641^113
 ;;^UTILITY(U,$J,358.3,15205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15205,1,3,0)
 ;;=3^Urethral Stricture,NOS,Female
 ;;^UTILITY(U,$J,358.3,15205,1,4,0)
 ;;=4^N35.92
 ;;^UTILITY(U,$J,358.3,15205,2)
 ;;=^5157413
 ;;^UTILITY(U,$J,358.3,15206,0)
 ;;=R82.81^^56^641^101
 ;;^UTILITY(U,$J,358.3,15206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15206,1,3,0)
 ;;=3^Pyuria
 ;;^UTILITY(U,$J,358.3,15206,1,4,0)
 ;;=4^R82.81
 ;;^UTILITY(U,$J,358.3,15206,2)
 ;;=^101879
 ;;^UTILITY(U,$J,358.3,15207,0)
 ;;=N18.30^^56^641^17
 ;;^UTILITY(U,$J,358.3,15207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15207,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3 Unspec
 ;;^UTILITY(U,$J,358.3,15207,1,4,0)
 ;;=4^N18.30
 ;;^UTILITY(U,$J,358.3,15207,2)
 ;;=^5159286
 ;;^UTILITY(U,$J,358.3,15208,0)
 ;;=N18.31^^56^641^18
 ;;^UTILITY(U,$J,358.3,15208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15208,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3a
 ;;^UTILITY(U,$J,358.3,15208,1,4,0)
 ;;=4^N18.31
 ;;^UTILITY(U,$J,358.3,15208,2)
 ;;=^5159287
 ;;^UTILITY(U,$J,358.3,15209,0)
 ;;=N18.32^^56^641^19
 ;;^UTILITY(U,$J,358.3,15209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15209,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3b
 ;;^UTILITY(U,$J,358.3,15209,1,4,0)
 ;;=4^N18.32
 ;;^UTILITY(U,$J,358.3,15209,2)
 ;;=^5159288
 ;;^UTILITY(U,$J,358.3,15210,0)
 ;;=G44.1^^56^642^10
 ;;^UTILITY(U,$J,358.3,15210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15210,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,15210,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,15210,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,15211,0)
 ;;=G43.909^^56^642^6
 ;;^UTILITY(U,$J,358.3,15211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15211,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,15211,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,15211,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,15212,0)
 ;;=G44.009^^56^642^1
 ;;^UTILITY(U,$J,358.3,15212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15212,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,15212,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,15212,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,15213,0)
 ;;=G44.40^^56^642^5
 ;;^UTILITY(U,$J,358.3,15213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15213,1,3,0)
 ;;=3^Medication Overuse Headache,Not Intractable
 ;;^UTILITY(U,$J,358.3,15213,1,4,0)
 ;;=4^G44.40
 ;;^UTILITY(U,$J,358.3,15213,2)
 ;;=^5003947
 ;;^UTILITY(U,$J,358.3,15214,0)
 ;;=G44.89^^56^642^2
 ;;^UTILITY(U,$J,358.3,15214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15214,1,3,0)
 ;;=3^Headache Syndrome NEC
 ;;^UTILITY(U,$J,358.3,15214,1,4,0)
 ;;=4^G44.89
 ;;^UTILITY(U,$J,358.3,15214,2)
 ;;=^5003954
 ;;^UTILITY(U,$J,358.3,15215,0)
 ;;=G44.84^^56^642^8
 ;;^UTILITY(U,$J,358.3,15215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15215,1,3,0)
 ;;=3^Primary Exertional Headache
 ;;^UTILITY(U,$J,358.3,15215,1,4,0)
 ;;=4^G44.84
 ;;^UTILITY(U,$J,358.3,15215,2)
 ;;=^336563
 ;;^UTILITY(U,$J,358.3,15216,0)
 ;;=G44.301^^56^642^7
 ;;^UTILITY(U,$J,358.3,15216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15216,1,3,0)
 ;;=3^Post-Traumatic Headache,Unspec,Intractable
 ;;^UTILITY(U,$J,358.3,15216,1,4,0)
 ;;=4^G44.301
 ;;^UTILITY(U,$J,358.3,15216,2)
 ;;=^5003941
 ;;^UTILITY(U,$J,358.3,15217,0)
 ;;=G44.209^^56^642^9
 ;;^UTILITY(U,$J,358.3,15217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15217,1,3,0)
 ;;=3^Tension-Type Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,15217,1,4,0)
 ;;=4^G44.209
 ;;^UTILITY(U,$J,358.3,15217,2)
 ;;=^5003936
 ;;^UTILITY(U,$J,358.3,15218,0)
 ;;=R51.0^^56^642^3
 ;;^UTILITY(U,$J,358.3,15218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15218,1,3,0)
 ;;=3^Headache w/ Orthostatic Component,NEC
 ;;^UTILITY(U,$J,358.3,15218,1,4,0)
 ;;=4^R51.0
 ;;^UTILITY(U,$J,358.3,15218,2)
 ;;=^5159305
 ;;^UTILITY(U,$J,358.3,15219,0)
 ;;=R51.9^^56^642^4
 ;;^UTILITY(U,$J,358.3,15219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15219,1,3,0)
 ;;=3^Headache,Unspec
 ;;^UTILITY(U,$J,358.3,15219,1,4,0)
 ;;=4^R51.9
 ;;^UTILITY(U,$J,358.3,15219,2)
 ;;=^5159306
 ;;^UTILITY(U,$J,358.3,15220,0)
 ;;=I30.0^^56^643^5
 ;;^UTILITY(U,$J,358.3,15220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15220,1,3,0)
 ;;=3^Idiopathic Pericarditis,Acute Nonspec
 ;;^UTILITY(U,$J,358.3,15220,1,4,0)
 ;;=4^I30.0
 ;;^UTILITY(U,$J,358.3,15220,2)
 ;;=^5007157
 ;;^UTILITY(U,$J,358.3,15221,0)
 ;;=I34.8^^56^643^6
 ;;^UTILITY(U,$J,358.3,15221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15221,1,3,0)
 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
 ;;^UTILITY(U,$J,358.3,15221,1,4,0)
 ;;=4^I34.8
 ;;^UTILITY(U,$J,358.3,15221,2)
 ;;=^5007172
 ;;^UTILITY(U,$J,358.3,15222,0)
 ;;=I34.0^^56^643^13
 ;;^UTILITY(U,$J,358.3,15222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15222,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,15222,1,4,0)
 ;;=4^I34.0
 ;;^UTILITY(U,$J,358.3,15222,2)
 ;;=^5007169
 ;;^UTILITY(U,$J,358.3,15223,0)
 ;;=I34.9^^56^643^12
 ;;^UTILITY(U,$J,358.3,15223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15223,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,15223,1,4,0)
 ;;=4^I34.9
 ;;^UTILITY(U,$J,358.3,15223,2)
 ;;=^5007173
 ;;^UTILITY(U,$J,358.3,15224,0)
 ;;=I34.2^^56^643^7
 ;;^UTILITY(U,$J,358.3,15224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15224,1,3,0)
 ;;=3^Nonrhematic Mitral Valve Stenosis
 ;;^UTILITY(U,$J,358.3,15224,1,4,0)
 ;;=4^I34.2
 ;;^UTILITY(U,$J,358.3,15224,2)
 ;;=^5007171
 ;;^UTILITY(U,$J,358.3,15225,0)
 ;;=I35.0^^56^643^10
 ;;^UTILITY(U,$J,358.3,15225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15225,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,15225,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,15225,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,15226,0)
 ;;=I35.1^^56^643^9
 ;;^UTILITY(U,$J,358.3,15226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15226,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,15226,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,15226,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,15227,0)
 ;;=I35.2^^56^643^11
 ;;^UTILITY(U,$J,358.3,15227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15227,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,15227,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,15227,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,15228,0)
 ;;=I35.9^^56^643^8
 ;;^UTILITY(U,$J,358.3,15228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15228,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,15228,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,15228,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,15229,0)
 ;;=I38.^^56^643^4
 ;;^UTILITY(U,$J,358.3,15229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15229,1,3,0)
 ;;=3^Endocarditis,Valve Unspec
 ;;^UTILITY(U,$J,358.3,15229,1,4,0)
 ;;=4^I38.
 ;;^UTILITY(U,$J,358.3,15229,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,15230,0)
 ;;=I05.0^^56^643^18
 ;;^UTILITY(U,$J,358.3,15230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15230,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,15230,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,15230,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,15231,0)
 ;;=I05.8^^56^643^19
 ;;^UTILITY(U,$J,358.3,15231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15231,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,15231,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,15231,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,15232,0)
 ;;=I05.9^^56^643^20
 ;;^UTILITY(U,$J,358.3,15232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15232,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,15232,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,15232,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,15233,0)
 ;;=I07.1^^56^643^21
 ;;^UTILITY(U,$J,358.3,15233,1,0)
 ;;=^358.31IA^4^2
